Cowen analyst Max Masucci initiates coverage on MaxCyte Inc. (NASDAQ: MXCT) with an Outperform rating.The analyst commented, "MaxCyte provides exposure ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE